Pharsight

Jazz Pharms patents expiration

1. Luvox Cr patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7465462 JAZZ PHARMS Multiparticulate controlled release selective serotonin reuptake inhibitor formulations
May, 2020

(4 years ago)

Drugs and Companies using FLUVOXAMINE MALEATE ingredient

Market Authorisation Date: 28 February, 2008

Treatment: Treatment of obsessive compulsive disorder treatable with an ssri

Dosage: CAPSULE, EXTENDED RELEASE;ORAL

How can I launch a generic of LUVOX CR before it's drug patent expiration?
More Information on Dosage

LUVOX CR family patents

Family Patents

2. Xyrem patents expiration

XYREM's oppositions filed in EPO
XYREM IPR and PTAB Proceedings
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8859619 JAZZ PHARMS Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
Dec, 2019

(4 years ago)

US8952062 JAZZ PHARMS Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
Dec, 2019

(4 years ago)

US7851506 JAZZ PHARMS Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
Dec, 2019

(4 years ago)

US8324275 JAZZ PHARMS Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
Dec, 2019

(4 years ago)

US9539330 JAZZ PHARMS Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
Dec, 2019

(4 years ago)

US8263650 JAZZ PHARMS Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
Dec, 2019

(4 years ago)

US9539330

(Pediatric)

JAZZ PHARMS Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
Jun, 2020

(3 years ago)

US7851506

(Pediatric)

JAZZ PHARMS Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
Jun, 2020

(3 years ago)

US8263650

(Pediatric)

JAZZ PHARMS Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
Jun, 2020

(3 years ago)

US8324275

(Pediatric)

JAZZ PHARMS Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
Jun, 2020

(3 years ago)

US8859619

(Pediatric)

JAZZ PHARMS Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
Jun, 2020

(3 years ago)

US8952062

(Pediatric)

JAZZ PHARMS Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
Jun, 2020

(3 years ago)

US7262219 JAZZ PHARMS Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
Jul, 2020

(3 years ago)

US6780889 JAZZ PHARMS Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
Jul, 2020

(3 years ago)

US6780889

(Pediatric)

JAZZ PHARMS Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
Jan, 2021

(3 years ago)

US7262219

(Pediatric)

JAZZ PHARMS Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
Jan, 2021

(3 years ago)

US8457988 JAZZ PHARMS Sensitive drug distribution system and method
Dec, 2022

(1 year, 5 months ago)

US8589182 JAZZ PHARMS Sensitive drug distribution system and method
Dec, 2022

(1 year, 5 months ago)

US7895059 JAZZ PHARMS Sensitive drug distribution system and method
Dec, 2022

(1 year, 5 months ago)

US8731963 JAZZ PHARMS Sensitive drug distribution system and method
Dec, 2022

(1 year, 5 months ago)

US8589182

(Pediatric)

JAZZ PHARMS Sensitive drug distribution system and method
Jun, 2023

(11 months ago)

US8731963

(Pediatric)

JAZZ PHARMS Sensitive drug distribution system and method
Jun, 2023

(11 months ago)

US7895059

(Pediatric)

JAZZ PHARMS Sensitive drug distribution system and method
Jun, 2023

(11 months ago)

US8457988

(Pediatric)

JAZZ PHARMS Sensitive drug distribution system and method
Jun, 2023

(11 months ago)

US7765107 JAZZ PHARMS Sensitive drug distribution system and method
Jun, 2024

(21 hours from now)

US7765106 JAZZ PHARMS Sensitive drug distribution system and method
Jun, 2024

(21 hours from now)

US7668730 JAZZ PHARMS Sensitive drug distribution system and method
Jun, 2024

(21 hours from now)

US7765106

(Pediatric)

JAZZ PHARMS Sensitive drug distribution system and method
Dec, 2024

(6 months from now)

US7668730

(Pediatric)

JAZZ PHARMS Sensitive drug distribution system and method
Dec, 2024

(6 months from now)

US7765107

(Pediatric)

JAZZ PHARMS Sensitive drug distribution system and method
Dec, 2024

(6 months from now)

US11253494 JAZZ PHARMS Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
Mar, 2033

(8 years from now)

US9050302 JAZZ PHARMS Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
Mar, 2033

(8 years from now)

US8772306 JAZZ PHARMS Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
Mar, 2033

(8 years from now)

US10864181 JAZZ PHARMS Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
Mar, 2033

(8 years from now)

US10213400 JAZZ PHARMS Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
Mar, 2033

(8 years from now)

US9486426 JAZZ PHARMS Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
Mar, 2033

(8 years from now)

US10213400

(Pediatric)

JAZZ PHARMS Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
Sep, 2033

(9 years from now)

US8772306

(Pediatric)

JAZZ PHARMS Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
Sep, 2033

(9 years from now)

US9050302

(Pediatric)

JAZZ PHARMS Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
Sep, 2033

(9 years from now)

US9486426

(Pediatric)

JAZZ PHARMS Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
Sep, 2033

(9 years from now)

US10864181

(Pediatric)

JAZZ PHARMS Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
Sep, 2033

(9 years from now)

US11253494

(Pediatric)

JAZZ PHARMS Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
Sep, 2033

(9 years from now)

Drug Exclusivity Drug Exclusivity Expiration
Orphan Drug Exclusivity(ODE-231) Oct 26, 2025
Pediatric Exclusivity(PED) Apr 26, 2026
New Patient Population(NPP) Oct 26, 2021
Orphan Drug Exclusivity(ODE) Nov 18, 2012

Drugs and Companies using SODIUM OXYBATE ingredient

Market Authorisation Date: 17 July, 2002

Treatment: Method of treating cataplexy in patients with narcolepsy; Method of treating excessive daytime sleepiness in patients with narcolepsy; Method of treating a patient with a prescription drug using a com...

Dosage: SOLUTION;ORAL

How can I launch a generic of XYREM before it's drug patent expiration?
More Information on Dosage

XYREM family patents

Family Patents